Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

MLA

Kobayashi, Eiji, et al. “Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.” Cells (2073-4409), vol. 12, no. 16, Aug. 2023, p. 2059. EBSCOhost, https://doi.org/10.3390/cells12162059.

APA

Kobayashi, E., Kamihara, Y., Arai, M., Wada, A., Kikuchi, S., Hatano, R., Iwao, N., Susukida, T., Ozawa, T., Adachi, Y., Kishi, H., Dang, N. H., Yamada, T., Hayakawa, Y., Morimoto, C., & Sato, T. (2023). Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. Cells (2073-4409), 12(16), 2059. https://doi.org/10.3390/cells12162059

Chicago

Kobayashi, Eiji, Yusuke Kamihara, Miho Arai, Akinori Wada, Shohei Kikuchi, Ryo Hatano, Noriaki Iwao, et al. 2023. “Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.” Cells (2073-4409) 12 (16): 2059. doi:10.3390/cells12162059.